Found: 251
Select item for more details and to access through your institution.
Novel nonsteroidal inhibitor of cytochrome P450<sub>17α</sub> (17α-hydroxylase/C17-20 lyase), YM116, decreased prostatic weights by reducing serum concentrations of testosterone and adrenal androgens in rats.
- Published in:
- Prostate, 1998, v. 37, n. 1, p. 10, doi. 10.1002/(SICI)1097-0045(19980915)37:1<10::AID-PROS3>3.0.CO;2-C
- By:
- Publication type:
- Article
Long-term outcomes of combined androgen blockade therapy in stage IV prostate cancer.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2015, v. 141, n. 4, p. 759, doi. 10.1007/s00432-014-1856-3
- By:
- Publication type:
- Article
Age at diagnosis on prostate cancer survival undergoing androgen deprivation therapy as primary treatment in daily practice: results from Japanese observational cohort.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2014, v. 140, n. 7, p. 1197, doi. 10.1007/s00432-014-1638-y
- By:
- Publication type:
- Article
Nadir prostate-specific antigen (PSA) level and time to PSA nadir following primary androgen deprivation therapy as independent prognostic factors in a Japanese large-scale prospective cohort study (J-CaP).
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2014, v. 140, n. 4, p. 673, doi. 10.1007/s00432-014-1612-8
- By:
- Publication type:
- Article
Evaluation of quality of life in patients with previously untreated advanced prostate cancer receiving maximum androgen blockade therapy or LHRHa monotherapy: a multicenter, randomized, double-blind, comparative study.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2008, v. 134, n. 12, p. 1385, doi. 10.1007/s00432-008-0409-z
- By:
- Publication type:
- Article
Prospective randomized trial of natural interferon-alpha versus natural interferon-alpha plus cimetidine in advanced renal cell carcinoma with pulmonary metastasis.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2006, v. 132, n. 8, p. 499, doi. 10.1007/s00432-006-0095-7
- By:
- Publication type:
- Article
Chemoprevention of rat prostate carcinogenesis by use of finasteride or casodex.
- Published in:
- JNCI: Journal of the National Cancer Institute, 1995, v. 87, n. 11, p. 842, doi. 10.1093/jnci/87.11.842
- By:
- Publication type:
- Article
Overall survival and good tolerability of long-term use of sorafenib after cytokine treatment: final results of a phase II trial of sorafenib in Japanese patients with metastatic renal cell carcinoma.
- Published in:
- BJU International, 2011, v. 108, n. 11, p. 1813, doi. 10.1111/j.1464-410X.2011.10281.x
- By:
- Publication type:
- Article
The liposome-incorporating cell wall skeleton of Mycobacterium bovis bacillus Calmette-Guéin can directly enhance the susceptibility of cancer cells to lymphokine-activated killer cells through up-regulation of natural-killer group 2, member D ligands
- Published in:
- BJU International, 2011, v. 108, n. 9, p. 1520, doi. 10.1111/j.1464-410X.2010.10056.x
- By:
- Publication type:
- Article
Maintenance therapy with bacillus Calmette-Guérin Connaught strain clearly prolongs recurrence-free survival following transurethral resection of bladder tumour for non-muscle-invasive bladder cancer.
- Published in:
- BJU International, 2011, v. 108, n. 2, p. 187, doi. 10.1111/j.1464-410X.2010.09891.x
- By:
- Publication type:
- Article
Immunoprotection against murine bladder carcinoma by octaarginine-modified liposomes incorporating cell wall of Mycobacterium bovis bacillus Calmette-Guérin.
- Published in:
- BJU International, 2009, v. 103, n. 5, p. 686, doi. 10.1111/j.1464-410X.2008.08235.x
- By:
- Publication type:
- Article
Urinary cytology and nuclear matrix protein 22 in the detection of bladder cancer recurrence other than transitional cell carcinoma.
- Published in:
- BJU International, 2008, v. 101, n. 5, p. 561, doi. 10.1111/j.1464-410X.2007.07352.x
- By:
- Publication type:
- Article
Global update on defining and treating high-risk localized prostate cancer with leuprorelin: an Asian perspective.
- Published in:
- BJU International, 2007, v. 99, p. 6, doi. 10.1111/j.1464-410X.2007.06592.x
- By:
- Publication type:
- Article
Global update on defining and treating high-risk localized prostate cancer with leuprorelin: a Japanese perspective – the effect of primary androgen deprivation therapy on stage C prostate cancer.
- Published in:
- BJU International, 2007, v. 99, p. 10, doi. 10.1111/j.1464-410X.2007.06593.x
- By:
- Publication type:
- Article
Efficacy of primary hormone therapy for localized or locally advanced prostate cancer: results of a 10-year follow-up.
- Published in:
- BJU International, 2006, v. 98, n. 3, p. 573, doi. 10.1111/j.1464-410X.2006.06349.x
- By:
- Publication type:
- Article
Institutional variability in the accuracy of urinary cytology for predicting recurrence of transitional cell carcinoma of the bladder.
- Published in:
- BJU International, 2006, v. 97, n. 5, p. 997, doi. 10.1111/j.1464-410X.2006.06036.x
- By:
- Publication type:
- Article
Uroepithelial cells can directly respond to Mycobacterium bovis bacillus Calmette-Guérin through Toll-like receptor signalling.
- Published in:
- BJU International, 2006, v. 97, n. 4, p. 860, doi. 10.1111/j.1464-410X.2006.06026.x
- By:
- Publication type:
- Article
Chemopreventive effects of cyclooxygenase-2 inhibitor and epidermal growth factor-receptor kinase inhibitor on rat urinary bladder carcinogenesis.
- Published in:
- BJU International, 2006, v. 97, n. 3, p. 640, doi. 10.1111/j.1464-410X.2006.06053.x
- By:
- Publication type:
- Article
randomized controlled trial evaluating the effect of low-dose chlormadinone in patients with low-risk prostate cancer: PROSAS study.
- Published in:
- Japanese Journal of Clinical Oncology, 2022, v. 52, n. 2, p. 187, doi. 10.1093/jjco/hyab162
- By:
- Publication type:
- Article
Cost-effectiveness analysis of enzalutamide for patients with chemotherapy-naïve metastatic castration-resistant prostate cancer in Japan.
- Published in:
- Japanese Journal of Clinical Oncology, 2021, v. 51, n. 8, p. 1319, doi. 10.1093/jjco/hyab071
- By:
- Publication type:
- Article
Surviving cancer in Asia: cross-boundary cancer studies, University of Tokyo.
- Published in:
- Japanese Journal of Clinical Oncology, 2021, v. 51, p. i4, doi. 10.1093/jjco/hyaa210
- By:
- Publication type:
- Article
Lecture No. 2 Is UHC for cancer in Asia an achievable goal?
- Published in:
- Japanese Journal of Clinical Oncology, 2021, v. 51, p. i9, doi. 10.1093/jjco/hyaa211
- By:
- Publication type:
- Article
Real-world use of temsirolimus in Japanese patients with unresectable or metastatic renal cell carcinoma: recent consideration based on the results of a post-marketing, all-case surveillance study.
- Published in:
- Japanese Journal of Clinical Oncology, 2020, v. 50, n. 8, p. 940, doi. 10.1093/jjco/hyaa062
- By:
- Publication type:
- Article
Post-marketing observational study of everolimus in patients with unresectable or metastatic renal cell carcinoma in Japan.
- Published in:
- Japanese Journal of Clinical Oncology, 2019, v. 49, n. 10, p. 956, doi. 10.1093/jjco/hyz081
- By:
- Publication type:
- Article
Report of the forth Asian Prostate Cancer (A-CaP) study meeting.
- Published in:
- Japanese Journal of Clinical Oncology, 2019, v. 49, n. 6, p. 581, doi. 10.1093/jjco/hyz053
- By:
- Publication type:
- Article
NCCN Asia Consensus Statement prostate cancer.
- Published in:
- Japanese Journal of Clinical Oncology, 2018, v. 48, n. 11, p. 964, doi. 10.1093/jjco/hyy116
- By:
- Publication type:
- Article
Joint Symposium of Korean Cancer Association & UICC-ARO--Cross-boundary cancer studies: cancer and Universal Health Coverage (UHC) in Asia.
- Published in:
- Japanese Journal of Clinical Oncology, 2017, v. 47, n. 9, p. 889, doi. 10.1093/jjco/hyx074
- By:
- Publication type:
- Article
Efficacy and safety of sequential use of everolimus in Japanese patients with advanced renal cell carcinoma after failure of first-line treatment with vascular endothelial growth factor receptor tyrosine kinase inhibitor: a multicenter phase II clinical trial
- Published in:
- Japanese Journal of Clinical Oncology, 2017, v. 47, n. 6, p. 551, doi. 10.1093/jjco/hyw194
- By:
- Publication type:
- Article
Efficacy and safety of a 3-month dosing regimen of degarelix in Japanese patients with prostate cancer: a phase II maintenance-dose-finding study.
- Published in:
- Japanese Journal of Clinical Oncology, 2017, v. 47, n. 5, p. 438, doi. 10.1093/jjco/hyx011
- By:
- Publication type:
- Article
Key predictive factors for efficacy of axitinib in first-line metastatic renal cell carcinoma: subgroup analysis in Japanese patients from a randomized, double-blind phase II study.
- Published in:
- Japanese Journal of Clinical Oncology, 2016, v. 46, n. 11, p. 1031, doi. 10.1093/jjco/hyw103
- By:
- Publication type:
- Article
What is the Asian Consensus Statement on NCCN clinical practice guidelines in oncology (NCCN-ACS)?
- Published in:
- Japanese Journal of Clinical Oncology, 2016, v. 46, n. 4, p. 299, doi. 10.1093/jjco/hyv202
- By:
- Publication type:
- Article
Urologic cancer in Japan: role of Japan at the frontier of issues in Asia.
- Published in:
- Japanese Journal of Clinical Oncology, 2016, v. 46, n. 1, p. 23, doi. 10.1093/jjco/hyv123
- By:
- Publication type:
- Article
Efficacy and safety of leuprorelin acetate 6-month depot in prostate cancer patients: a Phase III, randomized, open-label, parallel-group, comparative study in Japan.
- Published in:
- Japanese Journal of Clinical Oncology, 2015, v. 45, n. 12, p. 1168, doi. 10.1093/jjco/hyv149
- By:
- Publication type:
- Article
A large-scale prospective registration study of the safety and efficacy of sorafenib tosylate in unresectable ormetastatic renal cell carcinoma in Japan: results of over 3200 consecutive cases in post-marketing all-patient surveillance.
- Published in:
- Japanese Journal of Clinical Oncology, 2015, v. 45, n. 10, p. 953, doi. 10.1093/jjco/hyv099
- By:
- Publication type:
- Article
Real-world use of sunitinib in Japanese patients with advanced renal cell carcinoma: efficacy, safety and biomarker analyses in 1689 consecutive patients.
- Published in:
- Japanese Journal of Clinical Oncology, 2015, v. 45, n. 6, p. 576, doi. 10.1093/jjco/hyv045
- By:
- Publication type:
- Article
A Phase 2 Study of Abiraterone Acetate in Japanese Men with Metastatic Castration-resistant Prostate Cancer Who Had Received Docetaxel-based Chemotherapy.
- Published in:
- Japanese Journal of Clinical Oncology, 2014, v. 44, n. 12, p. 1206, doi. 10.1093/jjco/hyu148
- By:
- Publication type:
- Article
Long-term Survival of Extremely Advanced Prostate Cancer Patients Diagnosed with Prostate-specific Antigen over 500 ng/ml.
- Published in:
- Japanese Journal of Clinical Oncology, 2014, v. 44, n. 12, p. 1227, doi. 10.1093/jjco/hyu142
- By:
- Publication type:
- Article
A Phase 2 Trial of Abiraterone Acetate in Japanese Men with Metastatic Castration-resistant Prostate Cancer and without Prior Chemotherapy (JPN-201 Study).
- Published in:
- Japanese Journal of Clinical Oncology, 2014, v. 44, n. 12, p. 1216, doi. 10.1093/jjco/hyu149
- By:
- Publication type:
- Article
Recent Trends in the Initial Therapy for Newly Diagnosed Prostate Cancer in Japan.
- Published in:
- Japanese Journal of Clinical Oncology, 2014, v. 44, n. 10, p. 969, doi. 10.1093/jjco/hyu104
- By:
- Publication type:
- Article
Cross-boundary Cancer Studies at the University of Tokyo: View from the World of Science and Reason.
- Published in:
- Japanese Journal of Clinical Oncology, 2014, v. 44, n. suppl_1, p. i3, doi. 10.1093/jjco/hyt228
- By:
- Publication type:
- Article
Cross-boundary Cancer Studies at the University of Tokyo: Surviving Cancer in Asia: Introduction.
- Published in:
- Japanese Journal of Clinical Oncology, 2014, v. 44, n. suppl_1, p. i1, doi. 10.1093/jjco/hyt231
- By:
- Publication type:
- Article
Final Results of a Phase II Study of S-1 in Patients with Cytokine-refractory Metastatic Renal Cell Carcinoma.
- Published in:
- Japanese Journal of Clinical Oncology, 2014, v. 44, n. 2, p. 122, doi. 10.1093/jjco/hyt185
- By:
- Publication type:
- Article
Decreased expression of α-catenin is associated with poor prognosis of patients with localized renal cell carcinoma.
- Published in:
- International Journal of Cancer, 1997, v. 74, n. 5, p. 523, doi. 10.1002/(SICI)1097-0215(19971021)74:5<523::AID-IJC8>3.0.CO;2-5
- By:
- Publication type:
- Article
Clinical evaluation of urothelial tumors of the renal pelvis and ureter based on a new classification system.
- Published in:
- 1987
- By:
- Publication type:
- journal article
Mutual neoplastic promotion by instillation of mitomycin C and cauterization on rat bladder urothelium.
- Published in:
- 1986
- By:
- Publication type:
- journal article
Restoration by levamisole of E-rosette formation and its abrogation by autochthonous serum from patients with bladder cancer.
- Published in:
- 1979
- By:
- Publication type:
- journal article
Effectiveness and adverse effects of hormonal therapy for prostate cancer: Japanese experience and perspective.
- Published in:
- Asian Journal of Andrology, 2012, v. 14, n. 3, p. 451, doi. 10.1038/aja.2011.121
- By:
- Publication type:
- Article
Risk for intravesical recurrence of bladder cancer stratified by the results on two consecutive UroVysion fluorescence in situ hybridization tests: a prospective follow-up study in Japan.
- Published in:
- International Journal of Clinical Oncology, 2020, v. 25, n. 6, p. 1163, doi. 10.1007/s10147-020-01634-9
- By:
- Publication type:
- Article
Clinical evaluation of two consecutive UroVysion fluorescence in situ hybridization tests to detect intravesical recurrence of bladder cancer: a prospective blinded comparative study in Japan.
- Published in:
- International Journal of Clinical Oncology, 2018, v. 23, n. 6, p. 1140, doi. 10.1007/s10147-018-1311-6
- By:
- Publication type:
- Article
A multicenter phase I/II study of enzalutamide in Japanese patients with castration-resistant prostate cancer.
- Published in:
- International Journal of Clinical Oncology, 2016, v. 21, n. 4, p. 773, doi. 10.1007/s10147-016-0952-6
- By:
- Publication type:
- Article